These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1585740)

  • 1. [Postpartum diabetes screening: value of fructosamine determination].
    Huter O; Brezinka C; Sölder E; Kölle D; Drexel H
    Zentralbl Gynakol; 1992; 114(1):18-24. PubMed ID: 1585740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of postpartum fructosamine for assessment of gestational diabetes--a suitable method?].
    Heyl W; Schröder W; Kitschke HJ
    Zentralbl Gynakol; 1995; 117(5):269-73. PubMed ID: 7793170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of serum fructosamine as a screening test for gestational diabetes mellitus.
    Vermes I; Zeyen LJ; van Roon E; Brandts H
    Horm Metab Res; 1989 Feb; 21(2):73-6. PubMed ID: 2722131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review.
    Sermer M; Naylor CD; Farine D; Kenshole AB; Ritchie JW; Gare DJ; Cohen HR; McArthur K; Holzapfel S; Biringer A
    Diabetes Care; 1998 Aug; 21 Suppl 2():B33-42. PubMed ID: 9704225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between amniotic fluid glucose concentration and amniotic fluid volume and neonatal birth weight in pregnancy complicated by gestational diabetes mellitus].
    Xu ZM; Wu LF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):724-8. PubMed ID: 17327026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance.
    Di Cianni G; Miccoli R; Volpe L; Lencioni C; Ghio A; Giovannitti MG; Cuccuru I; Pellegrini G; Chatzianagnostou K; Boldrini A; Del Prato S
    Diabet Med; 2005 Jan; 22(1):21-5. PubMed ID: 15606686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for gestational diabetes mellitus in pregnant females.
    Ardawi MS; Nasrat HA; Jamal HS; Al-Sagaaf HM; Mustafa BE
    Saudi Med J; 2000 Feb; 21(2):155-60. PubMed ID: 11533772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for gestational diabetes mellitus.
    Kaufman HW
    Am Fam Physician; 1989 Dec; 40(6):109-11. PubMed ID: 2686372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructosamine in the management of gestational diabetes.
    Roberts AB; Baker JR; James AG; Henley P
    Am J Obstet Gynecol; 1988 Jul; 159(1):66-71. PubMed ID: 3394755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia.
    Leikin EL; Jenkins JH; Pomerantz GA; Klein L
    Obstet Gynecol; 1987 Apr; 69(4):570-3. PubMed ID: 3822298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between fetal growth and maternal fructosamine in diabetic pregnancy.
    Roberts AB; Baker JR
    Obstet Gynecol; 1987 Aug; 70(2):242-6. PubMed ID: 3299183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postpartum diagnosis of diabetes in pregnancy in fetal macrosomia--comparison of two examinations].
    Schäfer U; Dupak J; Dudenhausen J; Vetter K
    Z Geburtshilfe Perinatol; 1993; 197(6):257-61. PubMed ID: 8147044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose.
    Hillier TA; Pedula KL; Vesco KK; Schmidt MM; Mullen JA; LeBlanc ES; Pettitt DJ
    Obstet Gynecol; 2008 Nov; 112(5):1007-14. PubMed ID: 18978099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden.
    Aberg A; Rydhstroem H; Frid A
    Am J Obstet Gynecol; 2001 Jan; 184(2):77-83. PubMed ID: 11174484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes screening among women who gave birth to heavy infants. The result of 128 glucose tolerance tests during puerperium in women who gave birth to infants weighing 4,500 gram or more, and establishing the screening procedures in Danish maternity clinics].
    Nielsen GL; Nielsen PH
    Ugeskr Laeger; 1991 Jul; 153(31):2176-8. PubMed ID: 1866830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Macrosomia and maternal insulinemia in gestational diabetes].
    Rey E
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(4):471-4. PubMed ID: 2199567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maternal and fetal outcomes in pregnant women with abnormal glucose metabolism].
    Sun WJ; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):377-81. PubMed ID: 17697597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma glucose levels in glucose-intolerant women and newborn macrosomia.
    Verma A; Mitchell BF; Demianczuk N; Flowerdew G; Okun NB
    J Matern Fetal Med; 1997; 6(3):187-93. PubMed ID: 9172064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of fructosamine measurement in pregnant women with abnormal glucose tolerance.
    Li K; Yang HX
    Chin Med J (Engl); 2006 Nov; 119(22):1861-5. PubMed ID: 17134583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.